Head-to-head comparison of [68Ga]Ga-PSMA-11 and [18F]FDG PET/CT in multiple myeloma
European Journal of Nuclear Medicine and Molecular Imaging · 2023-07 · 50 (8) · 2432-2440
DOI: 10.1007/s00259-023-06214-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 29.03.2023. Verfasst von Stephan P M Souza und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nuclear Medicine, School of Medical Sciences University of Campinas (UNICAMP), Campinas, Brazil. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Multiple Myeloma. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo-FAPESP, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brazil-CAPES, Conselho Nacional de Desenvolvimento Científico e Tecnológico-CNPq.
Abstract (Originalsprache)
PURPOSE: The aim of this study was to compare [18F]FDG and [68Ga]Ga-PSMA-11 PET/CT image findings in patients with multiple myeloma (MM). METHODS: Twenty consecutive patients with symptomatic biopsy-proven MM were submitted to whole body [18F]FDG and [68Ga]Ga-PSMA-11 PET/CT with a time interval of 1-8 days between procedures. All lesions were counted and had their maximum SUV (SUVmax) measured. Intra-class correlation (ICC) was used to assess the agreement between [18F]FDG and [68Ga]Ga-PSMA-11 PET/CT findings. RESULTS: A total of 266 lesions were detected in 19/20 patients. [18F]FDG detected 223/266 (84%) lesions in 17 patients and [68Ga]Ga-PSMA-11 190/266 (71%) lesions in 19 patients. Both procedures did not identify any active lesion in 1 patient. Forty-three (16%) lesions were detected only by [68Ga]Ga-PSMA-11 and 76 (29%) only by [18F]FDG. Both tracers identified 147 (55%) lesions. Intralesional mismatch of FDG-PSMA uptake was identified in 25 of these 147 lesions, found in 8 different patients. Different lesions with uptake of only [18F]FDG or [68Ga]Ga-PSMA-11 in the same patient were found in 4 patients. The highest SUVmax of [18F]FDG and [68Ga]Ga-PSMA-11 had a median (min-max) SUVmax of 6.5 (2.0-37.8) and 5.5 (1.7-51.3), respectively. [18F]FDG and [68Ga]Ga-PSMA-11 respectively identified 18 and 19 soft tissue lesions. False-positive [18F]FDG findings had minimal or no uptake of [68Ga]Ga-PSMA-11. Good reliability (ICC ≥ 0.75) was found for number of lesions, number of soft tissue lesions and highest SUVmax in each patient. CONCLUSION: [18F]FDG or [68Ga]Ga-PSMA-11 alone can detect most MM lesions. Almost half of the lesions take up only one of the tracers, reflecting increased glycolysis or angiogenesis in specific lesions, and suggesting their possible complementary role in MM. The marked [68Ga]Ga-PSMA-11 uptake in some cases raises the possibility of a theranostic approach in selected patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nuclear Medicine, School of Medical Sciences University of Campinas (UNICAMP), Campinas, Brazil.
- Gleb Wataghin Institute of Physics, University of Campinas (UNICAMP), Campinas, Brazil.
- Center of Hematology and Hemotherapy, University of Campinas (UNICAMP), Campinas, Brazil.
- Laboratory of Cell Signaling, Obesity and Comorbidities Research Center, University of Campinas (UNICAMP), Campinas, Brazil.
- Department of Internal Medicine, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil.
- Division of Nuclear Medicine, School of Medical Sciences University of Campinas (UNICAMP), Campinas, Brazil. cdramos@unicamp.br.
ORCID-Profile: Stephan P M Souza, Maria Emilia S Takahashi, Fernando V Pericole, Licio A Velloso, Carmino A De Souza, Irene Lorand-Metze, Allan O Santos, Celso D Ramos
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo-FAPESP
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brazil-CAPES
- Conselho Nacional de Desenvolvimento Científico e Tecnológico-CNPq
- Fundação de Amparo à Pesquisa do Estado de São Paulo—FAPESP
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brazil—CAPES
- Conselho Nacional de Desenvolvimento Científico e Tecnológico—CNPq
Zitieren
APA
Souza, S. P. M., Frasson, F. C., Takahashi, M. E. S., Duarte, G. B. O., Castro, V. P., Pericole, F. V., Velloso, L. A., De Souza, C. A., Lorand-Metze, I., Santos, A. O., & Ramos, C. D. (2023). Head-to-head comparison of [68Ga]Ga-PSMA-11 and [18F]FDG PET/CT in multiple myeloma. European Journal of Nuclear Medicine and Molecular Imaging, 50(8), 2432-2440. https://doi.org/10.1007/s00259-023-06214-3
Vancouver
Souza SPM, Frasson FC, Takahashi MES, Duarte GBO, Castro VP, Pericole FV, et al. Head-to-head comparison of [68Ga]Ga-PSMA-11 and [18F]FDG PET/CT in multiple myeloma. European Journal of Nuclear Medicine and Molecular Imaging. 2023;50(8):2432-2440. doi:10.1007/s00259-023-06214-3
BibTeX
@article{Souza2023,
author = {Souza, Stephan P M and Frasson, Fernanda C and Takahashi, Maria Emilia S and Duarte, Gislaine B O and Castro, Vania P and Pericole, Fernando V and Velloso, Licio A and De Souza, Carmino A and Lorand-Metze, Irene and Santos, Allan O and Ramos, Celso D},
title = {Head-to-head comparison of [68Ga]Ga-PSMA-11 and [18F]FDG PET/CT in multiple myeloma},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2023},
volume = {50},
number = {8},
pages = {2432--2440},
doi = {10.1007/s00259-023-06214-3}
}
EUVIMED